Vasculogenesis and Diabetic Erectile Dysfunction: How Relevant Is Glycemic Control?

Area of Science:

• Endocrinology and Metabolism
• Cardiovascular Research
• Regenerative Medicine

Background:

• Diabetes mellitus is a major cause of erectile dysfunction (ED) due to endothelial dysfunction (EDys).
• The role of Endothelial Progenitor Cells (EPCs) in diabetes-associated ED and the impact of glycemic control on EPC function remain unclear.
• Vasculogenesis mediated by EPCs is crucial for vascular health, but its link to diabetes-induced ED requires further investigation.

Purpose of the Study:

• To investigate the effects of diabetes and insulin therapy on bone marrow (BM) and circulating EPCs, testosterone, and Stromal Derived Factor-1 alpha (SDF-1α) levels.
• To assess the impact of glycemic control on EPC function, EPC modulators, and penile vascular health in diabetic rats.
• To evaluate penile SDF-1α protein expression in experimental and human diabetic cavernosal samples.

Main Methods:

• Streptozotocin-induced type 1 diabetes model in male Wistar rats, with groups including controls, untreated diabetics, and insulin-treated diabetics.
• Flow cytometry analysis of EPCs using CD34/CD133/VEGFR2/CXCR4 antigens.
• ELISA for systemic SDF-1α and testosterone levels; immunohistochemistry for penile SDF-1α protein expression in rat and human samples.

Main Results:

• Diabetic rats showed reduced BM-derived EPCs and increased circulating endothelial cells (CECs), which were normalized by insulin therapy.
• Insulin treatment restored systemic testosterone and SDF-1α levels, which were decreased in diabetic animals.
• Reduced SDF-1α protein expression in diabetic penile tissue (both experimental and human) was prevented by insulin treatment.

Conclusions:

• Insulin therapy effectively rescues diabetes-induced impairments in BM function, CEC levels, testosterone, and SDF-1α expression.
• Glycemic control is crucial for preventing diabetes-induced systemic and penile endothelial dysfunction.
• Improving endothelial damage and enhancing protective pathways through glycemic control is vital for managing diabetes-associated ED.